Patent Invalidation in Madrid.

A patent invalidation Madrid strategy begins with a fact that sets Spain apart from most of Europe: Spain never joined the Unified Patent Court, so the Spanish part of a European patent can only be revoked here, on Spanish soil, under Spanish law. While UPC countries route revocation through Luxembourg-supervised divisions, a patent asserted in Spain lives or dies in the commercial courts of Madrid, Barcelona and Valencia, or through the Spanish Patent and Trademark Office (Oficina Española de Patentes y Marcas, OEPM). Madrid seats the OEPM and most Spanish corporate headquarters, which makes it a central forum for validity fights in pharma, telecoms, energy and banking. PerspireIP builds invalidity-grade prior-art searches for the accused parties, generic and biosimilar entrants and licensees who have to defeat a patent inside this national system.

Why patent invalidation Madrid cases stay national

Spain is one of only three EU member states — with Croatia and Poland — that never joined the Agreement on a Unified Patent Court. Spain objected to a translation regime built only on English, German and French, challenged the unitary patent package at the Court of Justice in Cases C-146/13 and C-147/13, and, even after losing in 2015, chose to stay out. The practical consequence for validity is decisive.

Because Spain sits outside the system, the Unified Patent Court cannot touch the Spanish designation of a European patent. A UPC revocation judgment sweeps away a unitary patent, or a non-opted-out classical European patent, across the participating states — but the Spanish part is untouched. To clear a Spanish market, an accused party still has to win a nullity action in a Spanish court or a procedure before the OEPM. The national route is not a fallback; it is the only route.

That structure raises the stakes on the prior art. As the UPC reshapes the rest of Europe, a patent invalidation Madrid defendant cannot piggy-back on a pan-European revocation; the Spanish validity attack has to be assembled, dated and won on its own. The invalidity search is therefore the whole case, not a supporting exhibit, and it has to be built to satisfy a Spanish commercial court or the OEPM directly.

• Commercial courts (juzgados de lo mercantil) — hear patent nullity as a claim or counterclaim in Madrid, Barcelona and Valencia
• OEPM — grants Spanish patents and runs post-grant opposition plus patentee-initiated limitation and revocation
• EPO Opposition Division — central attack on the European patent within nine months of grant, which does reach the Spanish designation
• Audiencia Provincial and Tribunal Supremo — the appeal chain for a Spanish nullity judgment

The Spanish commercial courts that decide validity

Patent nullity in Spain is a judicial matter, heard by specialised commercial courts (juzgados de lo mercantil). Jurisdiction is concentrated: the General Council of the Judiciary has assigned patent cases to designated courts in Madrid, Barcelona and Valencia, later extended to Granada, Las Palmas, A Coruña and Bilbao. In Madrid, commercial courts 6 to 11 hold exclusive jurisdiction over patents, designs and trademarks; in Barcelona, courts 1, 4 and 5 handle patents and designs.

Barcelona is widely regarded as the most experienced and preferred patent venue in Spain, with a deep bench in pharmaceutical and life-science disputes. Madrid, however, is a major forum in its own right: it seats the OEPM and the headquarters of most large Spanish and multinational corporates, so a great many assertions in telecoms, energy, banking technology and pharma are litigated in the capital. Unlike Austria’s bifurcated model, a Spanish defendant can attack validity in the same infringement proceeding.

Validity can be raised as a main nullity action or as a counterclaim to an infringement suit, so invalidity and infringement are usually heard together before one commercial court. A first-instance judgment is appealed to the Provincial Court (Audiencia Provincial), with a further appeal on points of law to the Supreme Court (Tribunal Supremo). Madrid therefore hosts a full validity chain, and the prior art has to hold up from first instance to last.

Spanish patent procedure leans heavily on expert evidence. Each side files a technical expert report, the court can appoint its own expert, and the decisive hearing often turns on cross-examination of those experts on novelty and inventive step. An invalidity search that arrives late, or that leaves a reference’s public-availability date open to challenge, hands the other side an easy answer. The art has to be complete, charted and dated before the expert report is drafted, not after.

Preliminary injunctions sharpen the timeline further. A patentee can seek interim relief to pull a product from the Spanish market before the merits are decided, and the strength of the defendant’s invalidity position is a core factor the court weighs. For a generic or biosimilar entrant timing a launch, a robust, ready-to-file prior-art dossier is often the difference between holding the market and being enjoined out of it.

How the 2017 reform reshaped patent invalidation Madrid work

The modern Spanish system is young. The Patent Act (Ley 24/2015, de 24 de julio, de Patentes) entered into force on 1 April 2017 and replaced a 1986 statute that let applicants choose between a light-touch registration route and full examination. Under the old regime, many Spanish patents were granted without any substantive check on novelty or inventive step — a weakness that shaped how invalidity was argued for decades.

Ley 24/2015 ended that. It established a single granting procedure with mandatory substantive examination for every national application, bringing Spain into line with the European Patent Convention approach. The OEPM now examines novelty, inventive step, industrial applicability and sufficiency before grant, and a six-month post-grant opposition window lets third parties challenge the patent administratively, much as at the EPO.

For invalidity searchers, the reform cuts two ways. Patents granted before April 2017 may still carry the unexamined-era fragility that makes a well-dated prior-art reference lethal. Patents granted since then have survived a real examination, so defeating them demands art the examiner did not find — obscure non-patent literature, foreign-language disclosures or older families argued as an inventive-step combination. Knowing which regime a patent was granted under is the first strategic question in any Spanish matter.

The reform also changed the mix of patents in force in Spain. Many rights asserted today are the Spanish designations of European patents granted by the EPO, which sit alongside purely national OEPM patents and Spanish utility models. A European patent validated in Spain is, for validity purposes, a Spanish patent — and because Spain is outside the UPC, its Spanish part can only be revoked through the Spanish courts or an EPO opposition, never through a UPC revocation. Mapping exactly what kind of right you are attacking, and where it was examined, drives the whole search strategy.

The OEPM route: opposition, limitation and revocation

Not every Spanish validity challenge goes to court. The OEPM, headquartered in Madrid, runs the administrative side of the system created by Ley 24/2015. Within six months of the grant being published, any third party can file a post-grant opposition, and the office can maintain, amend or revoke the patent on the same substantive grounds a court would apply — failure to meet patentability requirements, insufficient disclosure, or subject-matter extending beyond the application as filed.

The Act also gives the patent holder tools of its own. A proprietor can request administrative limitation of the claims, or outright revocation of its own patent, before the OEPM at any time during the patent’s life — often a defensive move to narrow a patent before or during litigation and dodge a broader nullity finding. An accused party has to anticipate that a claim set may shift under attack, and search the fallback positions, not just the granted claims.

Whether the fight is an OEPM opposition or a full nullity action in the commercial court, the substantive question is identical: was the invention genuinely new and inventive over what the public already had. That common core is why one rigorous invalidity search, charted claim by claim, can feed a six-month OEPM opposition, a court nullity counterclaim and a parallel EPO opposition on the same European patent at once.

The grounds and where Madrid’s decisive prior art lives

Spanish nullity grounds track the EPC. A patent can be revoked for lack of novelty or lack of inventive step, for insufficiency where the disclosure would not let a skilled person carry out the invention, for added matter extending beyond the application as filed, or because the subject-matter is not patentable at all. Novelty and inventive step dominate in practice, so the case turns on what was publicly available, and provably dated, before the priority date.

Madrid’s caseload follows the capital’s economy. It is a headquarters city for pharma and generics, for telecoms and standard-essential technology, for energy and utilities, and for banking and payments technology. Each cluster invalidates on different evidence, and the decisive reference is rarely the headline patent that a keyword search surfaces first. Spain’s large domestic generics sector, in particular, makes pharmaceutical validity fights a recurring feature of the Madrid docket, where a single formulation or dosage-regime claim can gate an entire market.

• Peer-reviewed journals and CAS-indexed chemistry for small-molecule, formulation and biosimilar claims
• Standards documents, contributions and technical specifications for telecoms and standard-essential patent claims
• Datasheets, application notes and product manuals for electronics, energy and metering claims
• Older and abandoned patent families used as novelty anticipations or inventive-step combinations under the problem-and-solution approach
• Foreign-language disclosures, theses and conference material an examiner is unlikely to have retrieved

The other half of the work is proof of date. A reference only counts if it was genuinely public before the priority date the claim relies on, so we treat public-availability dating as evidence — capturing print dates, archive timestamps, indexing dates and library records that a Spanish commercial court, the OEPM or an EPO Opposition Division can accept without argument.

How PerspireIP builds a patent invalidation Madrid case

Every engagement follows the same disciplined path. We map the asserted claims element by element, fix the priority date that actually governs each one, and search against that date rather than the filing date printed on the cover. For pharma and biotech subject-matter we run patent and deep non-patent-literature retrieval in parallel; for telecoms and electronics we add standards, contributions and datasheets. Then we build claim charts a Spanish forum can follow line by line, in Spanish and English.

• Claim charting mapped to novelty and inventive step under Ley 24/2015 and the EPC problem-and-solution approach
• Parallel patent and non-patent-literature searching tuned to pharma, telecoms, energy or banking-technology claims
• A read on the grant regime — pre-2017 unexamined patents versus post-reform examined patents — to target the weakest link
• Public-availability dating evidenced for every reference, ready for a commercial court or the OEPM
• Prior art sized to your forum — a court nullity action or counterclaim, a six-month OEPM opposition, or the nine-month EPO opposition window on the European patent

We work alongside your Spanish patent attorneys and European counsel as a specialist search partner, deliver to nullity, opposition and appeal deadlines, and keep every engagement confidential. Whether you are a manufacturer facing an infringement suit in the Madrid commercial courts, a generic or biosimilar entrant clearing a path, or litigation counsel coordinating a Spanish nullity action with a parallel EPO opposition, we scale to fit. Because Spain sits outside the UPC, the Spanish attack is the one no European judgment can win for you — send us the patent number and your key dates, and we will scope a patent invalidation Madrid project within one business day.

IP Landscape & Resources in Madrid

Key intellectual-property authorities and venues relevant to Madrid:

• Spanish Patent and Trademark Office (Oficina Española de Patentes y Marcas, OEPM) — the national office, headquartered in Madrid; it examines and grants Spanish patents and runs post-grant opposition plus patentee limitation and revocation under Ley 24/2015
• Consejo General del Poder Judicial (Spanish judiciary) — administers the specialised commercial courts (juzgados de lo mercantil) of Madrid, Barcelona and Valencia that decide patent nullity, with appeals to the Audiencia Provincial and Tribunal Supremo
• Ley 24/2015, de 24 de julio, de Patentes (BOE) — the Spanish Patent Act in force since 1 April 2017, which introduced mandatory substantive examination and the OEPM opposition, limitation and revocation procedures
• European Patent Office (EPO) — grants European patents and runs post-grant opposition within nine months of grant, a central attack that does reach the Spanish designation even though Spain is outside the UPC

Request a Patent Invalidation Search in Madrid

Explore related PerspireIP services: Patent Invalidation · Prior Art Litigation Search · Patent Infringement Analysis.

Frequently Asked Questions